Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Brooks

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infectionDavid G Brooks, Sang-Jun Ha, Heidi Elsaesser, et al.
Cell Reports|September 23, 2016
Overcoming CD4 Th1 Cell Fate Restrictions to Sustain Antiviral CD8 T Cells and Control Persistent Virus InfectionLaura M Snell, Ivan Osokine, Douglas H Yamada, et al.
Cell Host & Microbe|May 22, 2012
Emergence of distinct multiarmed immunoregulatory antigen-presenting cells during persistent viral infectionElizabeth B Wilson, Yoko Kidani, Heidi Elsaesser, et al.
Journal of the American Academy of Dermatology|October 18, 2007
Anabolic steroids causing growth of benign tumors: androgen receptor in angiolipomasSajjad P Syed, David G Brooks, Helen M Haupt, et al.
Journal of Personalized Medicine|January 7, 2015
Statin pharmacogenomics: opportunities to improve patient outcomes and healthcare costs with genetic testingWilliam J Canestaro, David G Brooks, Donald Chaplin, et al.
International Journal of Experimental Pathology|September 22, 2009
Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathwaysFeijun Luo, David G Brooks, Hongtao Ye, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 26, 2019
Correction: CRACR2A-Mediated TCR Signaling Promotes Local Effector Th1 and Th17 ResponsesJin Seok Woo, Sonal Srikanth, Kyun-Do Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2018
CRACR2A-Mediated TCR Signaling Promotes Local Effector Th1 and Th17 ResponsesJin Seok Woo, Sonal Srikanth, Kyun-Do Kim, et al.
Molecular Cancer Research : MCR|October 1, 2003
K-ras proto-oncogene exhibits tumor suppressor activity as its absence promotes tumorigenesis in murine teratomasRoberta M James, Mark J Arends, Sarah J Plowman, et al.
Investigative Ophthalmology & Visual Science|March 30, 2002
Ferritin crystal cataracts in hereditary hyperferritinemia cataract syndromeDavid G Brooks, Katia Manova-Todorova, Jennifer Farmer, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infectionDavid G Brooks, Sang-Jun Ha, Heidi Elsaesser, et al.
Cell Reports|September 23, 2016
Overcoming CD4 Th1 Cell Fate Restrictions to Sustain Antiviral CD8 T Cells and Control Persistent Virus InfectionLaura M Snell, Ivan Osokine, Douglas H Yamada, et al.
Cell Host & Microbe|May 22, 2012
Emergence of distinct multiarmed immunoregulatory antigen-presenting cells during persistent viral infectionElizabeth B Wilson, Yoko Kidani, Heidi Elsaesser, et al.
Journal of the American Academy of Dermatology|October 18, 2007
Anabolic steroids causing growth of benign tumors: androgen receptor in angiolipomasSajjad P Syed, David G Brooks, Helen M Haupt, et al.
Journal of Personalized Medicine|January 7, 2015
Statin pharmacogenomics: opportunities to improve patient outcomes and healthcare costs with genetic testingWilliam J Canestaro, David G Brooks, Donald Chaplin, et al.
International Journal of Experimental Pathology|September 22, 2009
Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathwaysFeijun Luo, David G Brooks, Hongtao Ye, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 26, 2019
Correction: CRACR2A-Mediated TCR Signaling Promotes Local Effector Th1 and Th17 ResponsesJin Seok Woo, Sonal Srikanth, Kyun-Do Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2018
CRACR2A-Mediated TCR Signaling Promotes Local Effector Th1 and Th17 ResponsesJin Seok Woo, Sonal Srikanth, Kyun-Do Kim, et al.
Molecular Cancer Research : MCR|October 1, 2003
K-ras proto-oncogene exhibits tumor suppressor activity as its absence promotes tumorigenesis in murine teratomasRoberta M James, Mark J Arends, Sarah J Plowman, et al.
Investigative Ophthalmology & Visual Science|March 30, 2002
Ferritin crystal cataracts in hereditary hyperferritinemia cataract syndromeDavid G Brooks, Katia Manova-Todorova, Jennifer Farmer, et al.
Pageof 10